Vaccination trial with HPV16 L1E7 chimeric virus‐like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)
Andreas M. Kaufmann(Charité - Universitätsmedizin Berlin), Achim Schneider(Gynecologic Oncology Group), Henryk Pilch(Heidelberg University), Harald Meissner(Medigene (Germany)), Elke Walek(Medigene (Germany)), Thomas Grubert(University of Washington), Lutz Gissmann(German Cancer Research Center), Reinhard Höpfl(Innsbruck Medical University), Ingrid Jochmus(Medigene (Germany)), Karl Ulrich Petry(Fraunhofer Project Centre Wolfsburg), Friederike Gieseking(Universität Hamburg), Birgit Glasschröder(Medigene (Germany)), Hans Ikenberg(Unknown), Michael Pawlita(DKFZ-ZMBH Alliance), Joseph Gabelsberger(Medigene (Germany)), John D. Nieland(Aalborg University), R. Müller(Medigene (Germany)), Anette Knoll(Statistisches Bundesamt), J. Schwarz(University Medical Center Hamburg-Eppendorf), Klaus Friese(München Klinik), S. Baur(Ludwig-Maximilians-Universität München), Volkmar Küppers(Heinrich Heine University Düsseldorf), Matthias Karrasch(Unknown), Peter Hillemanns(Medizinische Hochschule Hannover), Ralph J. Lellé, Martin Lechmann(Roche (Switzerland))
Cited by 136
Related Papers
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
Multiplex Human Papillomavirus Serology Based on In Situ–Purified Glutathione S-Transferase Fusion Proteins
|Clinical Chemistry|2005|588
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
|Nature Genetics|2009|484
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
|JNCI Journal of the National Cancer Institute|2015|441